Truist Securities Upgrades NovoCure to Buy
Truist Securities analyst Gregg Gilbert upgrades NovoCure (NASDAQ:NVCR) from Hold to Buy.
Cramer Gives His Opinion On Novocure, InMode, Virgin Galactic And More
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Atkore (NASDAQ: ATKR) is "just plain, perfect metal-bending company that I like."
Wells Fargo Maintains Equal-Weight on NovoCure, Lowers Price Target to $70
Wells Fargo analyst Larry Biegelsen maintains NovoCure (NASDAQ:NVCR) with a Equal-Weight and lowers the price target from $105 to $70.
10 Health Care Stocks With Whale Alerts In Today’s Session
This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Stocks Hitting New 52-Week Lows Today
On Monday morning, 60 companies achieved new lows for the year.
Evercore ISI Group Upgrades NovoCure to In-Line, Announces $82 Price Target
Evercore ISI Group analyst Vijay Kumar upgrades NovoCure (NASDAQ:NVCR) from Underperform to In-Line and announces $82 price target.
Novocure Reports Deal To Buy, Construct Building In Downtown Portsmouth, New Hampshire For $9.5M
Novocure (NASDAQ:NVCR) today announced that the company has signed a purchase and sale agreement to acquire and construct an office building at 64 Vaughan Mall, in the heart of downtown Portsmouth, New Hampshire. The
Novocure Posts Data For Tumor Treating Fields In Brain Tumor Trial
Novocure Ltd (NASDAQ:NVCR) has released updated data from the Phase 2 pilot 2-THE-TOP of Tumor Treating Fields (TTFields) together with pembrolizumab…
The Daily Biotech Pulse: Merck Reports Beat-And-Raise Quarter, Pfizer-BioNTech Snag Orders For Additional Vaccine Doses, HCW Cleared For Phase 1 Study Of Pancreatic Cancer Drug
Here's a roundup of top developments in the biotech space over the last 24 hours:
Recap: NovoCure Q3 Earnings
NovoCure (NASDAQ:NVCR) reported its Q3 earnings results on Thursday, October 28, 2021 at 06:00 AM.
Here's what investors need to know about the announcement.